ArticleTranslational andrology and urology2025
Comparative analgesic efficacy of erector spinae plane block versus quadratus lumborum block in laparoscopic renal cancer surgery: a double-blind randomized trial.
Article in Translational andrology and urology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07346417 (Erector Spinae Plane Block Versus Quadratus Lumborum Block for Post Operative Analgesia in Pediatric Kidney Surgery), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Erector Spinae Plane Block Versus Quadratus Lumborum Block for Post Operative Analgesia in Pediatric Kidney Surgery
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Ultrasound-guided erector spinae plane block (ESPB) and quadratus lumborum block (QLB) are increasingly used for perioperative analgesia. However, their comparative efficacy, opioid-sparing effects, and impact on recovery outcomes in patients undergoing laparoscopic renal cancer resection remain unclear. This study aimed to directly compare the analgesic effectiveness and recovery benefits of ESPB versus QLB in this surgical population. Methods: In this randomized, double-blind trial, 54 patients scheduled for laparoscopic nephrectomy were allocated to receive either ESPB or QLB with 25 mL of 0.4% ropivacaine under ultrasound guidance. Postoperative analgesia was managed using morphine-based patient-controlled analgesia. The primary outcome was cumulative morphine consumption within 6 hours postoperatively. Secondary outcomes included pain scores, morphine pump activations, the 15-item Quality of Recovery scale (QoR-15) scores, and length of hospital stay. Results: Patients receiving ESPB had significantly lower morphine consumption during the first 6 hours postoperatively compared to those receiving QLB (4.11±4.05 Conclusions: Compared with QLB, ESPB may provide more effective early postoperative analgesia and enhanced recovery in patients undergoing laparoscopic renal cancer surgery. These findings suggest that ESPB may be a valuable option for perioperative pain management in laparoscopic nephrectomy; however, as an exploratory study with limited sample size, further validation in larger populations is necessary. Trial Registration: Chinese Clinical Trial Registry, ChiCTR2300074743.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.